Brief: Humanigen Announces Late-Breaking Presentation At The Chest Annual Meeting Highlighting C-Reactive Protein As A Biomarker For Identifying Patients Most Likely To Benefit From Treatment With Lenzilumab

Humanigen

19/10/2021 12:28

Oct 19 (Reuters) - Humanigen Inc  HGEN.O :
    * HUMANIGEN ANNOUNCES LATE-BREAKING PRESENTATION AT THE
CHEST
ANNUAL MEETING HIGHLIGHTING C-REACTIVE PROTEIN AS A BIOMARKER
FOR IDENTIFYING PATIENTS MOST LIKELY TO BENEFIT FROM TREATMENT
WITH LENZILUMAB

Source text for Eikon:  ID:nBwcgP3vJa 
Further company coverage:  HGEN.O 

 ((reuters.briefs@thomsonreuters.com;))